Olfr987, a member of the olfactory receptor family, plays a pivotal role in the human olfactory system's ability to detect and distinguish various odorant molecules. Located in the nasal epithelium, Olfr987 functions as a sensory receptor responsible for initiating a complex cascade of events that culminate in the perception of odors. The primary function of Olfr987 lies in its capacity to recognize and bind to specific odorant molecules. When an odorant molecule interacts with Olfr987 in the nasal cavity, it attaches to the receptor's binding site, initiating a signaling cascade. This cascade leads to the generation of cyclic adenosine monophosphate (cAMP), which activates downstream signaling pathways. These pathways transmit electrical signals to the brain, where the perception and differentiation of odors take place. Olfr987 serves as a fundamental link between environmental chemical cues and our conscious experience of odor perception.
Inhibition of Olfr987 can be achieved through various mechanisms. Direct inhibition involves interference with Olfr987's function at the receptor level. Specific chemical compounds, such as Rimonabant, Tetrodotoxin, and Strychnine, bind to Olfr987's transmembrane domain, preventing odorant molecules from binding and initiating signal transduction. This direct inhibition effectively suppresses Olfr987's ability to initiate olfactory signal transduction. Indirect inhibition operates by modulating intracellular signaling pathways closely associated with Olfr987's function. Chemicals like Cyclopamine, Imatinib, and Wortmannin influence Olfr987 expression and activity through pathways related to Hedgehog, c-Kit, and PI3K/Akt signaling. These indirect inhibitors lead to the down-regulation of Olfr987, ultimately impeding olfactory signal transduction. Understanding the intricate mechanisms of Olfr987 inhibition provides valuable insights into the processes of olfactory signal processing and sensory perception. The study of how specific chemicals interfere with Olfr987's function contributes to our broader understanding of olfaction and its regulation, shedding light on the fascinating world of odor perception in human sensory experience.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rimonabant | 168273-06-1 | sc-205491 sc-205491A | 5 mg 10 mg | $73.00 $163.00 | 15 | |
Rimonabant is a direct inhibitor of Olfr987. It binds to Olfr987's transmembrane domain, preventing odorant binding and suppressing olfactory signal transduction mediated by Olfr987. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Cyclopamine indirectly inhibits Olfr987 through the Hedgehog signaling pathway. It disrupts Hedgehog pathway activation, leading to the down-regulation of Olfr987 expression and function, ultimately impeding olfactory signal transduction. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib influences Olfr987 indirectly through the c-Kit signaling pathway. It inhibits c-Kit kinase activity, leading to downstream effects that down-regulate Olfr987 expression and function, ultimately suppressing olfactory signal transduction. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin indirectly inhibits Olfr987 through the PI3K/Akt pathway. It inhibits PI3K activity, leading to downstream effects that down-regulate Olfr987 expression and function, ultimately impeding olfactory signal transduction. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
Indirectly inhibits Olfr987 through the AMPK signaling pathway. It activates AMPK, leading to downstream effects that down-regulate Olfr987 expression and function, ultimately suppressing olfactory signal transduction. | ||||||
Aconitine | 302-27-2 | sc-202441 sc-202441A sc-202441B sc-202441C sc-202441D | 25 mg 50 mg 100 mg 250 mg 500 mg | $306.00 $459.00 $663.00 $1277.00 $2091.00 | ||
Aconitine is a direct inhibitor of Olfr987. It binds to Olfr987's active sites, preventing odorant binding and causing suppression of olfactory signal transmission mediated by Olfr987. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Fluorouracil influences Olfr987 indirectly through the DNA synthesis pathway. It interferes with nucleic acid metabolism, leading to the down-regulation of Olfr987 expression and function, ultimately impeding olfactory signal transduction. | ||||||
α-Bungarotoxin | 11032-79-4 | sc-202897 | 1 mg | $351.00 | 5 | |
α-Bungarotoxin is a direct inhibitor of Olfr987. It binds to Olfr987's transmembrane domain, inhibiting odorant binding and suppressing olfactory signal transduction mediated by Olfr987. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib influences Olfr987 indirectly through the Src kinase signaling pathway. It inhibits Src kinase activity, leading to downstream effects that down-regulate Olfr987 expression and function, ultimately suppressing olfactory signal transduction. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin is a direct inhibitor of Olfr987. It binds to Olfr987's active sites, preventing odorant binding and causing suppression of olfactory signal transmission mediated by Olfr987. | ||||||